CD45是一种JAK酸酶,负调节细胞因子受体信号传递
J Irie-Sasaki1, T Sasaki, W Matsumoto
1Amgen Institute, Department of Medical Biophysics, University of Toronto, Ontario, Canada.
Nature
|February 24, 2001
概括
蛋白质氨酸酸酶CD45抑制了Janus激酶 (JAK) 的活性,揭示了在调节细胞因子受体信号传递方面发挥的新作用. 这一发现影响了对免疫细胞功能和发育的理解.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞信号传递 细胞信号传递
- 分子生物学分子生物学
背景情况:
- 蛋白氨酸酸酶 (PTPases) 和蛋白氨酸激酶调节细胞信号传递.
- CD45是一种跨膜PTPase,对T细胞和B细胞抗原受体信号传递至关重要.
- CD45的目标是Src家族的激酶,但它的广泛表达表明了其他作用.
研究的目的:
- 为了研究超出抗原受体信号传递的CD45的功能.
- 为了确定CD45是否调节细胞因子受体信号通路.
- 在造血细胞中识别CD45的新基质和功能.
主要方法:
- 基因向破坏小鼠中的cd45基因.
- 在体外生化测试以评估CD45-JAK相互作用.
- 对JAK/STAT通路激活和细胞反应 (增殖,造血,抗病毒活性) 的分析.
主要成果:
- CD45抑制了Janus激酶 (JAK) 的活性,并负面调节了细胞因子受体信号传递.
- 破坏cd45增强了通过细胞因子和干扰素受体激活JAK和STAT蛋白.
- 在体外,CD45直接去化并与JAK激酶结合.
- CD45负面调节介于interleukin-3的增殖,依赖于红色素的造血和抗病毒反应.
结论:
- CD45作为一个血液生成的JAK酸酶.
- CD45负面调节细胞因子受体信号通路.
- 这确定了CD45在调节免疫反应和血液形成中的新型作用.
相关概念视频
01:21Cell-surface Signaling
Hormones—or any molecule that binds to a receptor, known as a ligand—that are lipid-insoluble (water-soluble) are not able to diffuse across the cell membrane. In order to be able to affect a cell without entering it, these hormones bind to receptors on the cell membrane. When a first messenger, a hormone, binds to a receptor, a signal cascade is set off, causing second messengers, proteins inside the cell, to become activated, resulting in downstream effects.
01:22Amplifying Signals via Enzymatic Cascade
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
01:07Cell Signaling Feedback Loops
Positive and negative feedback loops are crucial for regulating biological signaling systems. These feedback loops are processes that connect output signals to their inputs.
Negative feedback loops
Most signaling systems have negative feedback loops that can perform different functions such as output limiter, and adaptation.
Output limiter
Upon receiving an input signal, the cellular response rapidly increases until a threshold is reached. Beyond this threshold, a negative feedback loop...
Negative feedback loops
Most signaling systems have negative feedback loops that can perform different functions such as output limiter, and adaptation.
Output limiter
Upon receiving an input signal, the cellular response rapidly increases until a threshold is reached. Beyond this threshold, a negative feedback loop...
01:07MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
01:16TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...